Emilio Alberto Rodríguez-Garay

Summary

Country: Argentina

Publications

  1. ncbi Adaptive hepatic changes in mild stenosis of the common bile duct in the rat
    E A Rodriguez-Garay
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones, Cientificas y Tecnicas, Universidad Nacional de Rosario, Argentina
    Res Exp Med (Berl) 198:307-23. 1999
  2. ncbi Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver
    C E Carnovale
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario, Argentina
    J Hepatol 32:798-804. 2000
  3. ncbi Insulin hyperresponsiveness in partially hepatectomized diabetic rats
    M C Carrillo
    Instituto de Fisiologia Experimental, CONICET, Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad Nacional de Rosario, Argentina
    Life Sci 68:1417-26. 2001
  4. ncbi Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis
    Enrique J Sanchez Pozzi
    Instituto de Fisiologia Experimental, Facultad de Ciencias Bioquimicas y Farmaceuticas, CONICET, Universidad Nacional de Rosario, Suipacha 570 2000 Rosario, Argentina
    J Pharmacol Exp Ther 306:279-86. 2003
  5. ncbi Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention
    F A Crocenzi
    Instituto de Fisiologia Experimental, CONICET Universidad Nacional de Rosario, Rosario, Argentina
    Curr Med Chem 11:501-24. 2004
  6. ncbi Cholestasis: human disease and experimental animal models
    Emilio Alberto Rodríguez-Garay
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad Nacional de Rosario, Rosario, Argentina
    Ann Hepatol 2:150-8. 2003

Collaborators

  • Aldo D Mottino
  • Viviana A Catania
  • Marcelo G Roma
  • M C Carrillo
  • C E Carnovale
  • F A Crocenzi
  • Enrique J Sanchez Pozzi
  • M L Alvarez
  • C Favre
  • Fernando A Crocenzi
  • Marcelo G Luquita
  • Emilio A Rodriguez Garay
  • Jose M Pellegrino
  • J A Monti
  • C Scapini
  • J Monti

Detail Information

Publications6

  1. ncbi Adaptive hepatic changes in mild stenosis of the common bile duct in the rat
    E A Rodriguez-Garay
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones, Cientificas y Tecnicas, Universidad Nacional de Rosario, Argentina
    Res Exp Med (Berl) 198:307-23. 1999
    ..These findings may explain the limited hepatic and systemic repercussion of experimental mild stenosis of the common bile duct and help us to understand the early stages of constriction of the common bile duct in man...
  2. ncbi Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver
    C E Carnovale
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario, Argentina
    J Hepatol 32:798-804. 2000
    ..We analysed the possible involvement of nitric oxide production in lipid peroxidation levels during liver regeneration...
  3. ncbi Insulin hyperresponsiveness in partially hepatectomized diabetic rats
    M C Carrillo
    Instituto de Fisiologia Experimental, CONICET, Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad Nacional de Rosario, Argentina
    Life Sci 68:1417-26. 2001
    ..In conclusion, increased expression of IR and IRS-1 leads to increased association of PI3K in vivo in diabetic regenerating rats. The enhancement of this pathway may reveal an insulin hyperresponsiveness in these animals...
  4. ncbi Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis
    Enrique J Sanchez Pozzi
    Instituto de Fisiologia Experimental, Facultad de Ciencias Bioquimicas y Farmaceuticas, CONICET, Universidad Nacional de Rosario, Suipacha 570 2000 Rosario, Argentina
    J Pharmacol Exp Ther 306:279-86. 2003
    ..In conclusion, both in vivo and in vitro experiments indicate that UDC decreased the metabolic pathways involved in EE glucuronidation, hence decreasing the formation of the cholestatic derivative EE 17beta-glucuronide...
  5. ncbi Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention
    F A Crocenzi
    Instituto de Fisiologia Experimental, CONICET Universidad Nacional de Rosario, Rosario, Argentina
    Curr Med Chem 11:501-24. 2004
    ..g., cAMP, silymarin or tauroursodeoxycholate) are described with respect to their ability to prevent cholestatic alterations; the role of signaling molecules as putative downstream mediators of their effects are also discussed...
  6. ncbi Cholestasis: human disease and experimental animal models
    Emilio Alberto Rodríguez-Garay
    Instituto de Fisiologia Experimental, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad Nacional de Rosario, Rosario, Argentina
    Ann Hepatol 2:150-8. 2003
    ..In conclusion, animal model and transport protein studies are necessary for the progressive understanding of congenital and acquired human cholestasis, and regulatory mechanisms that operate on liver cells...